Evidence map›Paper›PMID 25181039›Full record

ArticleJournal of the American Chemical Society2014

Discovery and characterization of a disulfide-locked C(2)-symmetric defensin peptide.

Andrew J Wommack, Joshua J Ziarek, Jill Tomaras, Haritha R Chileveru, Yunfei Zhang, Gerhard Wagner, Elizabeth M Nolan

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Conformational landscape and pathway of disulfide bond reduction of human alpha defensin.Protein science : a publication of the Protein Society · 2015
    Article
  10. Antimicrobial peptides in 2014.Pharmaceuticals (Basel, Switzerland) · 2015
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andrew J WommackDepartment of Chemistry, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.
Joshua J Ziarek
Jill Tomaras
Haritha R Chileveru
Yunfei Zhang
Gerhard Wagner
Elizabeth M Nolan

Funding

T CELL SPECIFIC TRANSCRIPTION COMPLEXESP01GM047467 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WAGNER, GERHARD · 1992 to 2017
$28.6M
OverallP41EB002026 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GRIFFIN, ROBERT GUY · 2003 to 2018
$17.9M
Antibacterial Peptides and Zinc in Innate Immunity and Mammalian PhysiologyDP2OD007045 · OD · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI NOLAN, ELIZABETH M · 2010 to 2010
$2.5M
STRUCTURAL BASIS FOR SCAP/SREBP INTERACTIONF32GM103005 · NIGMS · HARVARD MEDICAL SCHOOL · PI ZIAREK, JOSHUA JAMES · 2012 to 2014
$156k
NIBIB NIH HHS EB-002026NIBIB NIH HHS P41 EB002026NIGMS NIH HHS F32 GM103005NIGMS NIH HHS F32GM103005NIGMS NIH HHS P01 GM047467NIH HHS DP2 OD007045NIH HHS DP2OD007045
6 · The paper itself

Abstract

We report the discovery of HD5-CD, an unprecedented C2-symmetric β-barrel-like covalent dimer of the cysteine-rich host-defense peptide human defensin 5 (HD5). Dimerization results from intermonomer disulfide exchange between the canonical α-defensin Cys(II)-Cys(IV) (Cys(5)-Cys(20)) bonds located at the hydrophobic interface. This disulfide-locked dimeric assembly provides a new element of structural diversity for cysteine-rich peptides as well as increased protease resistance, broad-spectrum antimicrobial activity, and enhanced potency against the opportunistic human pathogen Acinetobacter baumannii.

Indexed as

Acinetobacter baumanniialpha-DefensinsAnti-Bacterial AgentsDimerizationDisulfidesHumansModels, MolecularStructure-Activity Relationshipalpha-DefensinsAnti-Bacterial AgentsDEFA5 protein, humanDisulfides

Identifiers

PMID25181039
PMCPMC4183617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.